Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029

Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029

The empty capsules market is projected to reach USD 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024, at a CAGR of 6.3% during the forecast period. This market's growth can be attributed to the growth in the pharmaceutical market, the increasing number of clinical trials and R&D activities, and the expansion of over-the-counter medications.

“The gelatin capsules segment accounted for the largest share by type in 2023.”

In 2023, the gelatin segment accounted for the largest share of type in the global empty capsules market. Factors such as availability of gelatin empty capsules in various colors, sizes, and printing options enables pharmaceutical companies to tailor their products to specific market segments, enhancing brand recognition and consumer appeal are expected to drive the segmeng growth.

““The Asia Pacific region is growing in the empty capsules market during the forecast period of 2024-2029.”

The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. The expanding pharmaceutical industry, combined with increasing healthcare spending, creates a strong demand for these capsules as crucial components in drug delivery systems. Additionally, the rising prevalence of chronic diseases and infectious illnesses necessitates diverse pharmaceutical formulations, further fueling the need for empty capsules. The growing awareness of preventive healthcare and the popularity of dietary supplements also contribute to market growth. Moreover, the region's robust manufacturing capabilities and cost-effective production methods enhance the accessibility of empty capsules across various pharmaceutical and nutraceutical applications. Additionally, favorable government policies and initiatives supporting healthcare infrastructure development and pharmaceutical innovation reinforce the market's expansion.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 80% and Demand Side 20%

By Designation: Managers - 35%, CXO & Directors - 20%, and Executives - 45%

By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Capsugel (Lonza) (Switzerland)

ACG (India)

QUALICAPS (Roquette Frères) (France)

SUHEUNG (South Korea)

Shanxi Guangsheng Capsule Limited (China)

CapsCanada (Lyfe Group) (US)

HealthCaps India (India)

Nectar Lifesciences Ltd. (India)

Sunil Healthcare Limited (India)

Farmacápsulas (Colombia)

NATURAL CAPSULES LIMITED (India)

Erawat Pharma Limited (India)

Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China)

Fortcaps ( Kumar Organic Products Limited) (India)

Comed Chemicals Limited (India)

Roxlor (US)

Medisca Inc. (US)

Zhejiang Yuexi Capsule Co. (China)

ZHEJIANG HUILI CAPSULES CO., LTD (China)

Shaoxing Zhongya Capsule Co., Ltd. (China)

Shing Lih Fang Enterprise Co., Ltd. (Taiwan)

Chemcaps Limited (India)

SNAIL PHARMA INDUSTRY (China)

SavoiurCaps (India)

Shanxi JC Biological Technology CO. (China)

Shaoxing Kangke Capsule Co., Ltd. (China)

Lefancaps (Canada)

BIO-CAPS INDIA LTD. (India)

BioCaps Enterprise (US)

Bright Pharma Caps (US)

SHREE PHARMA CAPS (India)

Research Coverage:

This research report categorizes the empty capsules market by ((non-gelatin capsules (hydroxypropyl methylcellulose (HPMC) capsules, and pullulan & starch capsules), and gelatin capsules (porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources), and), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), functionality (immediate-release capsules, sustained-release capsules, and delayed-release capsules), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories).

The report provides in-depth information on significant factors influencing the growth of the empty capsules market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches, mergers, and acquisitions within the empty capsules market.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (increasing demand for nutraceuticals and expansion of the Over-the-counter medications), restraints (cultural practices and dietary restrictions, and issues related to the safety and side effects of gelatin capsules), opportunities (expansion of capsule production in emerging countries and development of halal gelatin and vegetarian capsules), and challenges (rising prices and lower availability of raw materials in the gelatin industry and climate issues in the production and storage of empty capsules) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products of the empty capsules market

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the empty capsules market

Competitive Assessment: Capsugel (Lonza) (Switzerland), ACG (India), QUALICAPS (Roquette Frères) (France), SUHEUNG (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US), HealthCaps India (India), Nectar Lifesciences Ltd. (India), Sunil Healthcare Limited (India), Farmacápsulas (Colombia), NATURAL CAPSULES LIMITED (India), Erawat Pharma Limited (India), Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China), Fortcaps ( Kumar Organic Products Limited) (India), Comed Chemicals Limited (India), Roxlor (US), Medisca Inc. (US), Zhejiang Yuexi Capsule Co. (China), ZHEJIANG HUILI CAPSULES CO., LTD (China), Shaoxing Zhongya Capsule Co., Ltd. (China), Shing Lih Fang Enterprise Co., Ltd. (Taiwan), Chemcaps Limited (India), among others in the market.